CENTER CITY (WPVI) -- Jefferson University Hospital's Sidney Kimmel Cancer Center will begin tests soon on a new type of COVID-19 drug. It's based on disease-fighting T-cells, drawn from healthy ...

mRNA vaccines can enhance immunotherapy efficacy by activating the immune system, improving outcomes in hard-to-treat tumors. mRNA COVID-19 vaccines enhance immune responses, improving cancer ...

There's a new frontier in treating autoimmune diseases. Today's treatments tamp down the friendly fire but don't fix what's ...

This is where the COVID-19 vaccine comes in. A “hot” tumor is already swarming with T-cells. T-cells are some of the body ... a key that could unlock our body’s fight against cancer. It makes sense ...

SAN FRANCISCO (KGO) -- Among the mysteries surrounding novel coronavirus is its ability to turn deadly in some patients but not others. In a percentage of those fatal cases, it's the virus' effect on ...

COVID-19 mRNA vaccines may enhance the effects of immunotherapy drugs in cancer patients, potentially improving survival rates.

We can use AI to classify cell types, decode their language, and understand how they interact with one another—are the cells ...

The mass-produced COVID-19 vaccines built using the mRNA model – which were rapidly manufactured during the global pandemic – could also help the immune system recognise and attack cancer tumours, new ...

WASHINGTON – The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune systems to help fight tumors. People with advanced lung or skin ...